Forward Industries, Inc. (FORD) - Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended December 31, 2024 (Q1 Fiscal 2025). Forward Industries, Inc. operates two primary segments: OEM Distribution (sourcing and selling carrying cases/accessories for medical and electronic devices) and Design (hardware and software engineering services). The Company ceased its retail distribution segment in July 2023, with results reported as discontinued operations.
Key Financial Metrics
| Metric | Q1 2025 (Ended Dec 31, 2024) | Q1 2024 (Ended Dec 31, 2023) |
|---|---|---|
| Total Revenues | $6.62 million | $7.15 million |
| Gross Profit | $1.50 million | $1.64 million |
| Operating Loss | $(0.71) million | $(0.38) million |
| Net Loss | $(0.71) million | $(0.35) million |
| Loss Per Share (Basic & Diluted) | $(0.64) | $(0.32) |
| Cash and Cash Equivalents | $2.61 million | $3.03 million |
| Working Capital | $(0.16) million (Deficit) | $0.27 million (Surplus) |
| Total Assets | $13.49 million | $14.77 million |
| Total Liabilities | $11.21 million | $11.80 million |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased by 7.5% ($0.54 million). The Design segment saw a significant drop of 10.1% ($0.52 million), while OEM distribution remained relatively flat (-0.9%).
- Goodwill Impairment: The Company recorded a $225,000 non-cash goodwill impairment charge in the Design segment. This was triggered by the loss of a major customer's insulin patch pump program, which represented approximately 25.2% of consolidated revenue in the prior fiscal year.
- Segment Performance:
- OEM Distribution: Operating income improved to $223,000 (11.2% margin) from $41,000 (2.0% margin), driven by reduced sourcing fees and revenue mix changes.
- Design: Operating loss widened to $(260,000) from operating income of $266,000, primarily due to the impairment charge and lower billable hours.
- Liquidity: Cash used in operating activities was $0.41 million, compared to $0.12 million provided in the prior year. The Company now reports a working capital deficit of $162,000.
Outlook, Risks, and Management Commentary
- Going Concern Warning: Management has raised substantial doubt about the Company's ability to continue as a going concern for the 12 months following the filing date. Forecasted cash flows indicate existing balances may be insufficient to meet liquidity needs through February 2026.
- Customer Concentration Risk: The loss of the largest Design customer's insulin patch pump program is expected to cause a material decrease in revenues starting in Q2 Fiscal 2025.
- Cost Reductions: Management plans to initiate cost reduction measures, including a reduction in force communicated in December 2024.
- Financing Needs: The Company intends to seek debt or equity financing and negotiate flexible payment terms with its related-party supplier, Forward China. No agreements are currently in place.
- Nasdaq Compliance: The Company's stockholders' equity was below the $2.5 million threshold required by Nasdaq. To maintain compliance, the Company converted $2.2 million of related-party debt into Series A-1 Convertible Preferred Stock in 2024 and an additional $225,000 in February 2025 (subsequent event).
Investor Verification Checklist
- Going Concern Status: Verify the Company's ability to secure additional financing or extend payment terms with Forward China to avoid insolvency.
- Customer Concentration: Assess the impact of the lost insulin patch pump program on future Design segment revenue and the timeline for replacing this volume.
- Related Party Dependence: Review the terms of the supply agreement and debt arrangements with Forward China (owned by the CEO), which holds significant leverage over the Company's liquidity.
- Nasdaq Listing: Monitor the Company's stockholders' equity levels to ensure continued compliance with Nasdaq listing standards.
- Goodwill Valuation: Evaluate the remaining goodwill balance ($1.33 million) for potential future impairment charges if Design segment performance does not improve.